Diabetes & Endocrinology
Burosumab may enable near-normal lives for children with XLH.
Experts test intervention to improve sleep habits in pediatric patients with T1D.
Nationwide network to expand understanding beyond T1D and T2D.
Study looks toward alternative therapeutics.
1 / 5
A 12-month campaign successfully engages at-risk patient groups.
A trio of clinical trials is assessing CGM in distinct patient populations.
The Endocrine Feedback Loop offers a new take on the familiar academic forum.